Earnings Call Summary | Wag! Group(PET.US) Q1 2024 Earnings Conference
Earnings Call Summary | Wag! Group(PET.US) Q1 2024 Earnings Conference
The following is a summary of the Wag! Group Co (PET) Q1 2024 Earnings Call Transcript:
以下是 Wag 的摘要！集團公司（PET）2024年第一季度業績電話會議記錄：
Financial Performance:
財務業績：
Wag! Group Co reported Q1 2024 revenue of $23.2 million, a 13% increase year over year, and a new quarterly record.
The company's revenue boost was largely due to the success of the wellness business.
The company showed a positive EBITDA of $0.2 million, a significant increase from a loss reported during the same period in the previous year.
With an increase of 23%, the company achieved nearly $1.2 million in annualized revenue per employee in Q1 2024.
Wag! Group Co's B2B revenue represented the majority of its earnings, contributing 78% to the total Q1 2024 revenue.
Wag！集團公司報告稱，2024年第一季度收入爲2320萬美元，同比增長13％，創下季度新高。
該公司的收入增長主要歸因於健康業務的成功。
該公司的息稅折舊攤銷前利潤爲20萬美元，較去年同期公佈的虧損大幅增加。
公司在2024年第一季度實現了將近120萬美元的每名員工年化收入，增長了23％。
Wag！集團公司的B2B收入佔其收益的大部分，佔2024年第一季度總收入的78％。
Business Progress:
業務進展：
The company recently launched Furscription, a digital tool for veterinary staff to manage prescriptions, and WeCompare, a consumer brand for comparing various insurance products.
Due to successful AI and automation integrations, Wag! Group Co reduced its employee count by 8%.
The company made progress by increasing platform participation by 10% to a total of 671,000 participants in the first quarter.
Their future strategy focuses on reaching a balanced growth, profit and margin ratio, continuing to invest in proprietary customer acquisition, and expanding their premium wellness, service and products to more US households.
The second half of the year is expected to witness further growth acceleration, driven by the expiration of the prepayment penalty on the company's debt amongst other factors.
該公司最近推出了Furscription，這是一種供獸醫人員管理處方的數字工具，以及用於比較各種保險產品的消費品牌WeCompare。
由於成功集成了人工智能和自動化，Wag!集團公司將其員工人數減少了8％。
該公司在第一季度將平台參與度提高了10％，達到671,000名參與者，從而取得了進展。
他們未來的戰略側重於實現平衡的增長、利潤率和利潤率，繼續投資於專有客戶獲取，並將他們的優質健康、服務和產品擴展到更多的美國家庭。
受公司債務預付罰款到期等因素的推動，預計下半年的增長將進一步加速。
More details: Wag! Group IR
更多詳情： Wag！群組紅外線
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。